Polymethylmethacrylate dermal fillers: evaluation of the systemic toxicity in rats

C C G Medeiros1, R L Borghetti1, N Nicoletti2

  • 1Division of Oral Medicine, PUCRS, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil.

Insights

Intravascular injections of polymethylmethacrylate (PMMA) fillers may pose health risks. This study found potential for chronic inflammation at the injection site, particularly with higher concentrations.

Area of Science:

  • Biomaterials Science
  • Toxicology
  • Preclinical Research

Background:

  • Polymethylmethacrylate (PMMA) is utilized in various medical applications.
  • Understanding the local and systemic effects of intravascular PMMA injection is crucial.

Purpose of the Study:

  • To evaluate local and systemic reactions following intravascular injection of PMMA at different concentrations in a murine model.
  • To assess potential health risks associated with PMMA fillers.

Main Methods:

  • Thirty rats were divided into three groups: 2% PMMA, 30% PMMA, and saline control.
  • PMMA was injected into the ranine vein, with evaluations at 7 and 90 days.
  • Histopathological analysis of organs and lymph nodes, alongside serum biochemistry tests, was performed.

Main Results:

  • No systemic alterations or microsphere migration to distant organs were observed.
  • A local inflammatory response was noted in some samples from both 2% and 30% PMMA groups at different time points.
  • The 30% PMMA group showed elevated alanine aminotransferase levels at 90 days, indicating potential liver impact.

Conclusions:

  • Intravascular PMMA injections can lead to local inflammatory responses.
  • Higher PMMA concentrations may be associated with transient liver function alterations.
  • PMMA fillers carry potential health risks, including chronic inflammation at the implantation site.